About the event
5th International Congress on Epigenetics & Chromatin
August 22-23, 2019 Vienna, Austria
Epigenetics 2019 invites all the participants on behalf of organizing committee from all over the world to attend "5th International Congress on Epigenetics & Chromatin" which includes prompt keynote presentations, oral seminars, poster presentations and exhibitions.
The encompassing goal of this conference is to cover chromatin regulation, chromatin dynamics, signaling to chromatin, nuclear architecture and dynamics, developmental epigenetics, epigenomics, epigenetics and human diseases, genome stability, environmental epigenetics, Tran’s generational inheritance, functional genomics, system biology and super resolution microscopy.
Our aim is to provide Cancer Surgeons, Oncologists, Cardiologist, Neurologist, Pathologist, Gynecologist, Radiologist, Young researchers, Students, industrial delegates and anyone professionally involved in study of Epigenetics, Oncology, Genetics and Radiology and Imaging with an opportunity to learn about the complexity of the disease, discuss interventional procedures, look at new and advanced epigenetic practices and their efficiency and efficacy in the treatment of various Diseases and tumour extraction, and understand local realities and practical constraints in improving health-care.
Biochemical approaches of Epigenetics
Bioinformatics/ Computational Analysis of Epigenetics
Brain disorders & Epigenetics
Cancer Epigenetics & Oncology
Chromatin & its Dynamics
Epigenetics in Biotechnology & Developmental Biology
Environmental Epigenetic Factor
Epigenetics Market Products & Instrumentation
Epigenetics in Pharmacology & Drug Discovery
Epigenetics in reproductive health
Epigenetics in Nervous System
Epigenetics in Cardiovascular Disease
Epigenetics in Clinical Practice
Genetics & Epigenetic inheritance
Genomics and Epigenetics Division
Immunology in the epigenetic era
Need of Epigenetic Biomarkers
Why should you sponsor?
All the presentations were rated “excellent” by the majority, some attracted comments such as “great keynote”– really interesting and fascinating speaker”
The choice of venue was also very popular with the delegates: the majority rated the convenience of the location, its comfort and facilities and the catering as “excellent”
Of course, an enormous amount of effort goes into planning a conference such as this, and we owe thanks to all involved. First we are very grateful to the conference Exhibitor Sponsors Promega, Porvair Sciences Limited and Diagenode
A special vote thanks is due to our speakers, moderators, chairs, student rapporteurs, for their contributions on the day, as well as the hard work devoted to preparing for their roles.
Discover the epigenetic innovations of the future. Learn, collaborate and be inspired.
The global epigenetics market is projected to reach USD 1,605.7 Million by 2022 from USD 854.0 Million in 2017, at a CAGR of 13.5% during the forecast period. The growth in this market is primarily driven by the decreasing sequencing costs, increase in research activities, favorable government funding for epigenetics research, and rising prevalence of cancer.
High predominance of growth; expanding R and D financing; expanding force of examination exercises; expanding application for non-oncology sicknesses; and developing association between scholarly, biotechnology and pharmaceutical organizations are driving components of the epigenetics market.
The worldwide business sector of Epigenetics is fragmented in light of products, research territories and geology. By product, the business sector incorporates catalysts, instruments and consumables, packs and reagents. Catalysts are further subsegmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes.